查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
单核细胞增多症诊断市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按类型、最终用户和地理位置
市场调查报告书
商品编码
1624233

单核细胞增多症诊断市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按类型、最终用户和地理位置

Mononucleosis Diagnostic Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 210 Pages | 订单完成后即时交付

价格

根据我们关于「2031 年单核细胞增多症诊断市场预测 - 全球分析 - 按类型、最终用户和地理位置」的新研究，该市场预计将从 2023 年的 1.5144 亿美元增长到 2.2215 亿美元到2031 年；预计 2023 年至 2031 年复合年增长率为 4.9%。青少年族群的高风险以及对单核细胞增多症的健康意识和知识的不断提高，导致单核细胞增多症诊断市场规模不断扩大。然而，现有诊断测试的准确性较低阻碍了单核细胞增多症诊断市场的成长。此外，单核细胞增多症诊断中分子诊断的进步预计将在未来几年带来新的单核细胞增多症诊断市场趋势。

就收入而言，北美将在 2023 年主导单核细胞增多症诊断市场。美国是世界上最大的单核细胞增多症诊断市场，预计在预测期内也将主导该市场。美国单核细胞增多症诊断市场的成长归因于技术进步、意识提高以及对有效疾病管理策略的持续需求。根据美国国立卫生研究院的数据，美国每年记录约 125,000 例传染性单核球增多症病例。由于如此高的数字，该国对EB病毒（EBV）引起的单核细胞增多症的认识也在提高，这增加了对快速、准确的诊断检测试剂盒、耗材和服务的需求。该国医疗保健提供者采用的各种检测方法包括基于抗体检测的血清学检测和专注于病毒 DNA 识别的分子检测。美国单核细胞增多症诊断市场的竞争格局由雅培实验室、罗氏诊断和西门子医疗等公司主导。这些公司投资于创新和合作，以增强其产品供应并扩大其市场份额。

单核球增多症诊断市场分析

床边检测的发展为未来提供市场机会

POC 测试可以在患者护理现场或附近进行快速诊断，使医疗保健提供者能够立即做出临床决策并改善患者治疗结果。传统的实验室测试通常需要数小时或数天才能得出结果，这可能会延迟治疗并使症状恶化。相较之下，POC 测试可以在几分钟内得出结果，以便及时介入。快速週转对于单核细胞增多症等疾病尤其重要，因为早期诊断可以减少併发症并提高患者的舒适度。 POC 测试可以在各种医疗机构中实施，包括门诊诊所、急诊室和家庭护理机构。对于实验室基础设施有限的地区或医疗资源不足的农村地区，这种便利性尤其有利。以 POC 测试的形式使诊断能力更接近患者，确保更多的人得到及时的诊断和适当的护理，从而扩大医疗保健服务的范围。此外，这种类型的测试促进了更大的参与度，因为患者可以快速收到结果并与医疗保健提供者讨论后续步骤。

与传统实验室测试相比，POC 测试更具成本效益，因为它们不需要大量的实验室基础设施，从而降低了医疗保健系统的整体成本。单核细胞增多症检测的可负担性进一步推动了更广泛的患者的可及性，特别是在服务不足的人群中。生物感测器和微流体技术的最新进展正在推动更复杂的 POC 测试的发展，并提高灵敏度和特异性。这些创新确保了 POC 检测检测单核细胞增多症的可靠性。提供 POC 检测试剂盒的单核细胞增多症诊断市场参与者包括 SEKISUI Diagnostics (OSOM Mono Test)、Abbott (Clearview Mono) 和 Cardinal Health [Cardinal Health MONO (Mononucleosis) II Rapid Test]。因此，POC 测试的发展为单核细胞增多症诊断市场参与者带来了巨大的成长机会。

单核细胞增多症诊断市场报告細項分析

有助于单核细胞增多症诊断市场分析的关键部分是类型和最终用户。

根据类型，单核球增多症诊断市场分为EB病毒抗体检测、全血球计数检测及单点检测。 2023 年，单点测试领域占据了最大的单核细胞增多症诊断市场。

就最终用户而言，单核细胞增多症诊断市场分为医院、实验室等。 2023 年，医院细分市场将主导市场。

单核细胞增多症诊断市场：竞争格局与主要发展

Abbott Laboratories、Arlington Scientific Inc、Bio-Rad Laboratories Inc、Cardinal Health Inc、Meridian Bioscience Inc、Sekisui Diagnostics LLC、Thermo Fisher Scientific Inc、QuidelOrtho Corp、F. Hoffmann-La Roche Ltd、QIAGEN NV、Hologic Inc、bioieux Ltd、 DiaSorin SpA、Immunostics Inc.、Launch Diagnostics Ltd、Biorex Diagnostics 和ZEUS Scientific 是单核细胞增多症诊断市场的主要公司之一。

联合国儿童基金会(UNICEF)、国家医学图书馆、疾病管制与预防中心(CDC)、美国国立卫生研究院、加拿大统计局、联邦统计局(Destatis) 是准备报告时参考的主要和次要来源。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：

第 4 章：单核球增多症诊断市场格局

  • 概述
  • PEST分析

第 5 章：单核球增多症诊断市场 - 主要市场动态

  • 单核球增多症诊断市场 - 主要市场动态
  • 市场驱动因素
    • 青少年族群的高风险
    • 关于单核细胞增多症的健康意识和知识不断提高
  • 市场限制
    • 现有诊断测试的准确性较低
  • 市场机会
    • 即时检测的发展
  • 未来趋势
    • 分子诊断的进展
  • 驱动因素和限制的影响：

第 6 章：单核球增多症诊断市场 - 全球市场分析

  • 单核球增多症诊断市场收入，2021-2031
  • 单核球增多症诊断市场预测分析

第 7 章：单核球增多症诊断市场分析 - 按类型

  • 单点测试
  • Epstein 病毒抗体检测
  • 全血球计数测试

第 8 章：单核球增多症诊断市场分析 - 依最终用户

  • 医院
  • 实验室
  • 其他的

第 9 章：单核球增多症诊断市场 - 地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 中东和非洲其他地区

第 10 章：产业格局

  • 概述
  • 单核球增多症诊断市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 11 章：公司简介

  • Abbott Laboratories
  • Arlington Scientific Inc
  • Bio-Rad Laboratories Inc
  • Cardinal Health Inc
  • Meridian Bioscience Inc
  • Sekisui Diagnostics LLC
  • Thermo Fisher Scientific Inc
  • QuidelOrtho Corp
  • F. Hoffmann-La Roche Ltd
  • QIAGEN NV
  • Hologic Inc
  • bioMerieux SA
  • DiaSorin SpA
  • Immunostics Inc.
  • Launch Diagnostics Ltd
  • Biorex Diagnostics
  • ZEUS Scientific

第 12 章：附录

Product Code: TIPRE00019689

According to our new research study on "Mononucleosis Diagnostic Market Forecast to 2031 -Global Analysis - by Type, End User, and Geography," the market is anticipated to grow from US$ 151.44 million in 2023 and is projected to reach US$ 222.15 million by 2031; it is expected to register a CAGR of 4.9% during 2023-2031. High risk among the adolescent population, and the rising health awareness and knowledge about mononucleosis are contributing to the growing mononucleosis diagnostic market size. However, the low accuracy of existing diagnostic tests hampers the mononucleosis diagnostic market growth. Further, advancements in molecular diagnostics in mononucleosis diagnostic are expected to bring in new mononucleosis diagnostic market trends in the coming years.

In terms of revenue, North America dominated the mononucleosis diagnostic market in 2023. It is estimated to dominate the global market during the forecast period. The US is the largest market for mononucleosis diagnostics in the world, and it is estimated to dominate the market during the forecast period as well. The mononucleosis diagnostic market growth in the US is attributed to technological advancements, increased awareness, and a constant need for effective disease management strategies. According to the National Institutes of Health, the US records ~125,000 cases of infectious mononucleosis every year. Owing to such a high number, the awareness of the mononucleosis caused by the Epstein-Barr virus (EBV) is also on the rise in the country, which bolsters the demand for rapid and accurate diagnostic test kits, consumables, and services. Various testing methods adopted by healthcare providers in the country include serological tests based on antibody detection and molecular tests focused on viral DNA identification. The competitive landscape of the mononucleosis diagnostics market in the US is dominated by companies such as Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers. These companies invest in innovation and collaborations to enhance their product offerings and expand their market presence.

Mononucleosis Diagnostic Market Analysis

Development of Point-of-Care Testing to Provide Market Opportunities in Future

POC testing allows for rapid diagnosis at or near the site of patient care, enabling healthcare providers to make immediate clinical decisions and improve patient outcomes. Traditional laboratory tests often require hours or days to generate results, which can delay treatment and worsen symptoms. In contrast, POC tests can deliver results within minutes, facilitating timely intervention. The rapid turnaround is especially crucial for conditions such as mononucleosis, as early diagnosis can reduce complications and enhance patient comfort. POC testing can be implemented in various healthcare settings, including outpatient clinics, emergency departments, and home care settings. The accessibility is particularly beneficial in areas with limited laboratory infrastructure or in rural regions with insufficient healthcare resources. Bringing diagnostic capabilities closer to patients in the form of POC testing ensures that more individuals receive timely diagnoses and appropriate care, thereby broadening the reach of healthcare services. Moreover, this type of testing promotes greater engagement, as patients can receive their results quickly and discuss the next steps with their healthcare providers.

POC testing can be more cost-effective compared to traditional laboratory testing as they don't need extensive laboratory infrastructure, in turn lowering the overall costs for healthcare systems. The affordability of mononucleosis testing further drives its accessibility to a broader range of patients, especially in underserved populations. Recent advancements in biosensors and microfluidic technologies are driving the development of more sophisticated POC tests with improved sensitivity and specificity. These innovations ensure the reliability of POC tests in detecting mononucleosis. Mononucleosis diagnostic market players offering POC test kits include SEKISUI Diagnostics (OSOM Mono Test), Abbott (Clearview Mono), and Cardinal Health [Cardinal Health MONO (Mononucleosis) II Rapid Test]. Thus, the development of POC testing generates substantial growth opportunities for the mononucleosis diagnostics market players.

Mononucleosis Diagnostic Market Report Segmentation Analysis

Key segments that contributed to the derivation of the mononucleosis diagnostic market analysis are type and end user.

Based on type, the mononucleosis diagnostic market is segmented into Epstein Barr Virus antibody test, complete blood count test, and monospot test. The monospot test segment held the largest mononucleosis diagnostic market share of the market in 2023.

In terms of end user, the mononucleosis diagnostic market is categorized into hospitals, laboratories, and others. The hospitals segment dominated the market in 2023.

Mononucleosis Diagnostic Market: Competitive Landscape and Key Developments

Abbott Laboratories, Arlington Scientific Inc, Bio-Rad Laboratories Inc, Cardinal Health Inc, Meridian Bioscience Inc, Sekisui Diagnostics LLC, Thermo Fisher Scientific Inc, QuidelOrtho Corp, F. Hoffmann-La Roche Ltd, QIAGEN NV, Hologic Inc, bioMerieux SA, DiaSorin SpA, Immunostics Inc., Launch Diagnostics Ltd, Biorex Diagnostics, and ZEUS Scientific are among the key companies operating in the mononucleosis diagnostic market.

The United Nations Children's Fund (UNICEF), National Library of Medicine, Centers for Disease Control and Prevention (CDC), National Institutes of Health, Statistics Canada, Federal Statistical Office (Destatis) are among the primary and secondary sources referred to while preparing the mononucleosis diagnostic market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Mononucleosis Diagnostics Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Mononucleosis Diagnostics Market - Key Market Dynamics

  • 5.1 Mononucleosis Diagnostics Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 High Risk among Adolescent Population
    • 5.2.2 Rising Health Awareness and Knowledge About Mononucleosis
  • 5.3 Market Restraints
    • 5.3.1 Low Accuracy of Existing Diagnostic Tests
  • 5.4 Market Opportunities
    • 5.4.1 Development of Point-of-Care Testing
  • 5.5 Future Trends
    • 5.5.1 Advancements in Molecular Diagnostics
  • 5.6 Impact of Drivers and Restraints:

6. Mononucleosis Diagnostics Market - Global Market Analysis

  • 6.1 Mononucleosis Diagnostics Market Revenue (US$ Thousand), 2021-2031
  • 6.2 Mononucleosis Diagnostics Market Forecast Analysis

7. Mononucleosis Diagnostics Market Analysis - by Type

  • 7.1 Monospot Test
    • 7.1.1 Overview
    • 7.1.2 Monospot Test: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 7.2 Epstein Barr Virus Antibody Test
    • 7.2.1 Overview
    • 7.2.2 Epstein Barr Virus Antibody Test: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 7.3 Complete Blood Count Test
    • 7.3.1 Overview
    • 7.3.2 Complete Blood Count Test: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)

8. Mononucleosis Diagnostics Market Analysis - by End User

  • 8.1 Hospital
    • 8.1.1 Overview
    • 8.1.2 Hospital: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 8.2 Laboratories
    • 8.2.1 Overview
    • 8.2.2 Laboratories: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 8.3 Others
    • 8.3.1 Overview
    • 8.3.2 Others: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)

9. Mononucleosis Diagnostics Market - Geographical Analysis

  • 9.1 North America
    • 9.1.1 North America Mononucleosis Diagnostics Market Overview
    • 9.1.2 North America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    • 9.1.3 North America: Mononucleosis Diagnostics Market Breakdown, by Type
      • 9.1.3.1 North America: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Type
    • 9.1.4 North America: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.1.4.1 North America: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by End User
    • 9.1.5 North America: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Country
      • 9.1.5.1 United States: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.1.5.1.1 United States: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.1.5.1.2 United States: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.1.5.2 Canada: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.1.5.2.1 Canada: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.1.5.2.2 Canada: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.1.5.3 Mexico: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.1.5.3.1 Mexico: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.1.5.3.2 Mexico: Mononucleosis Diagnostics Market Breakdown, by End User
  • 9.2 Europe
    • 9.2.1 Europe Mononucleosis Diagnostics Market Overview
    • 9.2.2 Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.2.2.1 Europe: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Type
      • 9.2.2.2 Europe: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by End User
    • 9.2.3 Europe: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Country
      • 9.2.3.1 Germany: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.2.3.1.1 Germany: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.2.3.1.2 Germany: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.2.3.2 United Kingdom: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.2.3.2.1 United Kingdom: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.2.3.2.2 United Kingdom: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.2.3.3 France: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.2.3.3.1 France: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.2.3.3.2 France: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.2.3.4 Italy: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.2.3.4.1 Italy: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.2.3.4.2 Italy: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.2.3.5 Spain: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.2.3.5.1 Spain: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.2.3.5.2 Spain: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.2.3.6 Rest of Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.2.3.6.1 Rest of Europe: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.2.3.6.2 Rest of Europe: Mononucleosis Diagnostics Market Breakdown, by End User
  • 9.3 Asia Pacific
    • 9.3.1 Asia Pacific Mononucleosis Diagnostics Market Overview
    • 9.3.2 Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.3.2.1 Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Type
      • 9.3.2.2 Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by End User
    • 9.3.3 Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Country
      • 9.3.3.1 China: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.3.3.1.1 China: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.3.3.1.2 China: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.3.3.2 Japan: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.3.3.2.1 Japan: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.3.3.2.2 Japan: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.3.3.3 India: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.3.3.3.1 India: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.3.3.3.2 India: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.3.3.4 Australia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.3.3.4.1 Australia: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.3.3.4.2 Australia: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.3.3.5 South Korea: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.3.3.5.1 South Korea: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.3.3.5.2 South Korea: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.3.3.6 Rest of APAC: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.3.3.6.1 Rest of APAC: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.3.3.6.2 Rest of APAC: Mononucleosis Diagnostics Market Breakdown, by End User
  • 9.4 South and Central America
    • 9.4.1 South and Central America Mononucleosis Diagnostics Market Overview
    • 9.4.2 South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.4.2.1 South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Type
      • 9.4.2.2 South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by End User
    • 9.4.3 South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Country
      • 9.4.3.1 Brazil: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.4.3.1.1 Brazil: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.4.3.1.2 Brazil: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.4.3.2 Argentina: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.4.3.2.1 Argentina: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.4.3.2.2 Argentina: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.4.3.3 Rest of South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.4.3.3.1 Rest of South and Central America: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.4.3.3.2 Rest of South and Central America: Mononucleosis Diagnostics Market Breakdown, by End User
  • 9.5 Middle East and Africa
    • 9.5.1 Middle East and Africa Mononucleosis Diagnostics Market Overview
    • 9.5.2 Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.5.2.1 Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Type
      • 9.5.2.2 Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by End User
    • 9.5.3 Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Country
      • 9.5.3.1 Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Country
      • 9.5.3.2 Saudi Arabia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.5.3.2.1 Saudi Arabia: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.5.3.2.2 Saudi Arabia: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.5.3.3 South Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.5.3.3.1 South Africa: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.5.3.3.2 South Africa: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.5.3.4 United Arab Emirates: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.5.3.4.1 United Arab Emirates: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.5.3.4.2 United Arab Emirates: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.5.3.5 Rest of Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.5.3.5.1 Rest of Middle East and Africa: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.5.3.5.2 Rest of Middle East and Africa: Mononucleosis Diagnostics Market Breakdown, by End User

10. Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in Mononucleosis Diagnostic Market
  • 10.3 Organic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Inorganic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Abbott Laboratories
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Arlington Scientific Inc
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Bio-Rad Laboratories Inc
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Cardinal Health Inc
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Meridian Bioscience Inc
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Sekisui Diagnostics LLC
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Thermo Fisher Scientific Inc
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 QuidelOrtho Corp
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 F. Hoffmann-La Roche Ltd
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 QIAGEN NV
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments
  • 11.11 Hologic Inc
    • 11.11.1 Key Facts
    • 11.11.2 Business Description
    • 11.11.3 Products and Services
    • 11.11.4 Financial Overview
    • 11.11.5 SWOT Analysis
    • 11.11.6 Key Developments
  • 11.12 bioMerieux SA
    • 11.12.1 Key Facts
    • 11.12.2 Business Description
    • 11.12.3 Products and Services
    • 11.12.4 Financial Overview
    • 11.12.5 SWOT Analysis
    • 11.12.6 Key Developments
  • 11.13 DiaSorin SpA
    • 11.13.1 Key Facts
    • 11.13.2 Business Description
    • 11.13.3 Products and Services
    • 11.13.4 Financial Overview
    • 11.13.5 SWOT Analysis
    • 11.13.6 Key Developments
  • 11.14 Immunostics Inc.
    • 11.14.1 Key Facts
    • 11.14.2 Business Description
    • 11.14.3 Products and Services
    • 11.14.4 Financial Overview
    • 11.14.5 SWOT Analysis
    • 11.14.6 Key Developments
  • 11.15 Launch Diagnostics Ltd
    • 11.15.1 Key Facts
    • 11.15.2 Business Description
    • 11.15.3 Products and Services
    • 11.15.4 Financial Overview
    • 11.15.5 SWOT Analysis
    • 11.15.6 Key Developments
  • 11.16 Biorex Diagnostics
    • 11.16.1 Key Facts
    • 11.16.2 Business Description
    • 11.16.3 Products and Services
    • 11.16.4 Financial Overview
    • 11.16.5 SWOT Analysis
    • 11.16.6 Key Developments
  • 11.17 ZEUS Scientific
    • 11.17.1 Key Facts
    • 11.17.2 Business Description
    • 11.17.3 Products and Services
    • 11.17.4 Financial Overview
    • 11.17.5 SWOT Analysis
    • 11.17.6 Key Developments

12. Appendix

  • 12.1 About the Insight Partners
  • 12.2 Glossary of Terms for Mononucleosis Diagnostics Market

List Of Tables

  • Table 1. Mononucleosis Diagnostics Market Segmentation
  • Table 2. North America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 3. North America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 4. United States: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 5. United States: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 6. Canada: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 7. Canada: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 8. Mexico: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 9. Mexico: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 10. Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 11. Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 12. Germany: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 13. Germany: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 14. United Kingdom: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 15. United Kingdom: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 16. France: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 17. France: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 18. Italy: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 19. Italy: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 20. Spain: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 21. Spain: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 22. Rest of Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 23. Rest of Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 24. Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 25. Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 26. China: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 27. China: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 28. Japan: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 29. Japan: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 30. India: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 31. India: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 32. Australia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 33. Australia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 34. South Korea: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 35. South Korea: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 36. Rest of APAC: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 37. Rest of APAC: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 38. South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 39. South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 40. Brazil: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 41. Brazil: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 42. Argentina: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 43. Argentina: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 44. Rest of South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 45. Rest of South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 46. Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 47. Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 48. Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Country
  • Table 49. Saudi Arabia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 50. Saudi Arabia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 51. South Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 52. South Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 53. United Arab Emirates: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 54. United Arab Emirates: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 55. Rest of Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 56. Rest of Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 57. Recent Organic Growth Strategies in Mononucleosis Diagnostic Market
  • Table 58. Recent Inorganic Growth Strategies in the Mononucleosis Diagnostic Market
  • Table 59. Glossary of Terms

List Of Figures

  • Figure 1. Mononucleosis Diagnostics Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Mononucleosis Diagnostics Market Revenue (US$ Thousand), 2021-2031
  • Figure 5. Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 6. Mononucleosis Diagnostics Market Share (%) - by Type (2023 and 2031)
  • Figure 7. Monospot Test: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 8. Epstein Barr Virus Antibody Test: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 9. Complete Blood Count Test: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 10. Mononucleosis Diagnostics Market Share (%) - by End User (2023 and 2031)
  • Figure 11. Hospital: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 12. Laboratories: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 13. Others: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 14. North America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 15. North America: Mononucleosis Diagnostics Market Breakdown, by Type (2023 and 2031)
  • Figure 16. North America: Mononucleosis Diagnostics Market Breakdown, by End User (2023 and 2031)
  • Figure 17. North America: Mononucleosis Diagnostics Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 18. United States: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 19. Canada: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 20. Mexico: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 21. Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 22. Europe: Mononucleosis Diagnostics Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 23. Germany: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 24. United Kingdom: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 25. France: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 26. Italy: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 27. Spain: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 28. Rest of Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 29. Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 30. Asia Pacific: Mononucleosis Diagnostics Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 31. China: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 32. Japan: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 33. India: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 34. Australia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 35. South Korea: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 36. Rest of APAC: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 37. South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 38. South and Central America: Mononucleosis Diagnostics Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 39. Brazil: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 40. Argentina: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 41. Rest of South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 42. Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 43. Middle East and Africa: Mononucleosis Diagnostics Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 44. Saudi Arabia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 45. South Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 46. United Arab Emirates: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 47. Rest of Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 48. Growth Strategies in Mononucleosis Diagnostic Market